N,N-Diethyl-3-phenylbicyclo[2.2.1]heptan-2-amine (DiEt-Fencamfamin): general
DiEt-fencamfamin is listed in chemical databases as “DiEt-Fencamfamin” or “N-Ethylphencamfamin”, the N,N-diethyl form of fencamfamin.[1] It is fencamfamin, a prescription stimulant from the 1960s, with one more ethyl group on the nitrogen atom. The fencamfamin entry covers the parent drug. This page is a summary of what is known about DiEt-fencamfamin and what is not. It is not medical advice and it gives no amounts.
Where it comes from
The compound goes back to the same laboratory as fencamfamin. A German patent filed in 1960 by “E. Merck AG” covers a family of stimulant (analeptic) compounds of this shape, and among them names “2-Phenyl-3-diäthylaminobicyclo” heptane, the old German spelling of DiEt-fencamfamin.[2] In the company's animal tests, the patent claims a “deutliche Wirkungssteigerung”, a clear increase in effect, for several of these compounds over the older one they were compared with.[2] Fencamfamin went on to be prescribed from 1962.[3] As far as we could find, DiEt-fencamfamin stayed in the patent until it reappeared as a research chemical.[4]
What is known about it in people
Nothing published, as far as our search found. A PubMed search on 2026-11-21 under its several names returned two records, and neither is about this compound.[4] We found no clinical study, no case report and no laboratory analysis of products sold under the name. This page does not rely on users' forum reports, because nobody can confirm what was in the powder they took.
That means there is no established safe amount, no published information on how long it lasts, and no data on how it interacts with other drugs or with alcohol.[4] Whether a product sold as DiEt-fencamfamin contains it, and how pure it is, is unknown.
Risks inferred from its parent
Because nothing has been measured for DiEt-fencamfamin itself, the closest guide is fencamfamin. What follows is evidence about the parent drug and about stimulants in general, labelled as such. It is an inference, not a finding about this compound.
- Dependence. The World Health Organization's drug-dependence committee found that “fencamfamin is self-administered by both beagle dogs and monkeys and it shows the typical pattern of a central stimulant reinforcer”.[3] A study in dogs concluded that “FEN may have a cocaine-like abuse potential”.[5] Fencamfamin has been in “Schedule IV of the 1971 Convention on Psychotropic Substances” since that review.[3] A chemical relative may share that potential, and nobody has tested whether it does.
- Heart and blood pressure. In healthy volunteers, fencamfamin raised “heart rate, blood pressure and stimulation assessed by self-rating”.[6]
- Overdose. For stimulants in general, the US Centers for Disease Control and Prevention warns that “not all stimulant overdoses look the same”, and that “it is hard to know how much is 'too much' or harmful for any given person”.[7] Its list of signs that need medical attention includes a fast or irregular heartbeat, overheating, high blood pressure and “chest pains or tightness”.[7]
Those risks are greater for anyone with heart disease or high blood pressure, and when stimulants are combined. The legal section covers how the law treats a relative of a controlled drug that is not itself named.
References
- N-Ethylphencamfamin (DiEt-Fencamfamin), compound record 13258 — Isomer Design, PiHKAL·info
- DE1219478B: Verfahren zur Herstellung analeptisch wirksamer N-substituierter Aminonorcamphanderivate (E. Merck AG; filed 1960-12-23, published 1966-06-23) — Google Patents (German patent)
- Fencamfamin: ECDD technical summary and recommendation (22nd Expert Committee on Drug Dependence, 1985) — World Health Organization, Expert Committee on Drug Dependence information repository
- PubMed search for DiEt-fencamfamin under its names, and for fencamfamin analogues (run 2026-11-21: two records, neither about this compound) — PubMed (US National Library of Medicine)
- Intravenous self-administration of fencamfamine and cocaine by beagle dogs (Risner and Cone, Drug and Alcohol Dependence, 1986) — PubMed (US National Library of Medicine)
- Psychostimulant effects of fencamfamine in healthy volunteers (Gorenstein, DeLucia and Gentil, Brazilian Journal of Medical and Biological Research, 1988) — PubMed (US National Library of Medicine)
- Stimulant Guide: Overdose Prevention and Response (2024) — US Centers for Disease Control and Prevention
Comments
Sign in to join the conversation.
No comments yet.